Robert David Ross
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert David Ross has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
Antonio G. Cabrera
2 shared publications- David W. Brown
Department of Cardiology, Boston Children’s Hospital, MA (D.W.B.).
2 shared publications - Aamir Jeewa
Labatt Family Heart Centre, Division of Pediatric Cardiology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, Canada
1 shared publication - Ahmad Kaddourah
Nephrology Division
1 shared publication - Alejandro A. Floh
Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto
1 shared publication Alexander Hussey
1 shared publication
Latest Publications
- 25 March 2018
- Published by Tech Science Press in Congenital Heart Disease
- Vol. 13 (4) , 499-505
NT-pro BNP-A marker for worsening respiratory status and mortality in infants and young children with pulmonary hypertension
Aim To evaluate predictors of morbidity and mortality in pediatric patients with pulmonary hypertension (PH), laboratory and echocardiographic measures of PH were analyzed. Methods A retrospective review of all infants and children < 2 years of age with PH from January 2011 to August 2016 was conducted. Correlations were determined using Spearman's rank correlation coefficients. Differences in characteristics between survivors and nonsurvivors were analyzed and Kaplan‐Meier survival curves were generated. Results Of 56 patients, the majority were extremely premature; of African American ethnicity; and had bronchopulmonary dysplasia. Patients who died were more likely to have underlying congenital heart disease; have a higher increase in the concentration of carbon dioxide in the blood (pCO2) with a corresponding greater mean percentage decrease in pH and percentage rise in NT‐pro BNP during PH exacerbations; more likely to have been on medications for pulmonary hypertension; and have a higher RVSP/SBP (%) ratio and S/D ratio. There were positive correlations between percentage rise in NT‐pro BNP and pCO2; NT‐pro BNP and RVSP/SBP (%) ratio; and RVSP/SBP (%) ratio and S/D ratio. Conclusions Infants and young children with pulmonary hypertension have increased morbidity and mortality. NT‐pro BNP is a useful biomarker for both respiratory exacerbations and mortality, and RVSP/SBP (%) ratio and S/D ratio are echocardiographic identifiers for increased mortality.
- 25 March 2018
- Published by Tech Science Press in Congenital Heart Disease
- Vol. 13 (4) , 499-505
NT-pro BNP-A marker for worsening respiratory status and mortality in infants and young children with pulmonary hypertension
Aim To evaluate predictors of morbidity and mortality in pediatric patients with pulmonary hypertension (PH), laboratory and echocardiographic measures of PH were analyzed. Methods A retrospective review of all infants and children < 2 years of age with PH from January 2011 to August 2016 was conducted. Correlations were determined using Spearman's rank correlation coefficients. Differences in characteristics between survivors and nonsurvivors were analyzed and Kaplan‐Meier survival curves were generated. Results Of 56 patients, the majority were extremely premature; of African American ethnicity; and had bronchopulmonary dysplasia. Patients who died were more likely to have underlying congenital heart disease; have a higher increase in the concentration of carbon dioxide in the blood (pCO2) with a corresponding greater mean percentage decrease in pH and percentage rise in NT‐pro BNP during PH exacerbations; more likely to have been on medications for pulmonary hypertension; and have a higher RVSP/SBP (%) ratio and S/D ratio. There were positive correlations between percentage rise in NT‐pro BNP and pCO2; NT‐pro BNP and RVSP/SBP (%) ratio; and RVSP/SBP (%) ratio and S/D ratio. Conclusions Infants and young children with pulmonary hypertension have increased morbidity and mortality. NT‐pro BNP is a useful biomarker for both respiratory exacerbations and mortality, and RVSP/SBP (%) ratio and S/D ratio are echocardiographic identifiers for increased mortality.
- 23 January 2018
- Published by Springer Nature
- p. 369-382
Evaluation and Management of Pediatric Chest Pain, Syncope, and Murmur in the Emergency Department
- 23 January 2018
- Published by Springer Nature
- p. 369-382
Evaluation and Management of Pediatric Chest Pain, Syncope, and Murmur in the Emergency Department
- 23 January 2018
- Published by Springer Nature
- p. 219-234
Recognition, Stabilization, and Management of Children with Pulmonary Hypertension in the Emergency Department
- 23 January 2018
- Published by Springer Nature
- p. 219-234
Recognition, Stabilization, and Management of Children with Pulmonary Hypertension in the Emergency Department
- 1 January 2018
- Published by Elsevier
List of Contributors
- 1 March 2017
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 44, 67-71
The United States pediatric cardiology 2015 workforce assessment: A survey of current training and employment patterns
- 1 March 2017
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 44, 67-71
The United States pediatric cardiology 2015 workforce assessment: A survey of current training and employment patterns
- 5 February 2017
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 44
Preface - pediatric graduate medical education
- 5 February 2017
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 44
Preface - pediatric graduate medical education
- 6 August 2013
- Published by Springer Nature in Pediatric Cardiology
- Vol. 35 (2) , 232-238
Severity of Mitral Regurgitation Predicts Risk of Death or Cardiac Transplantation in Children With Idiopathic Dilated Cardiomyopathy
Clinical outcomes among children with idiopathic dilated cardiomyopathy (IDC) are diverse, which makes the decision as to when a patient should be listed for a cardiac transplantation challenging. This study aimed to determine echocardiographic and clinical variables that can help clinicians identify those at highest risk for death or cardiac transplantation. The study was a single-center, retrospective chart review of children with IDC. Patients younger than 18 years with a diagnosis of IDC, as defined by a left ventricular end-diastolic dimension (LVEDD) z-score higher than 2, and fractional shortening of less than 28 % on the initial echocardiogram, were included in the study. Echocardiographic parameters including mitral regurgitation (MR) grade and certain clinical parameters at the time of presentation were assessed. A follow-up echocardiogram was similarly studied. The study included 49 children with IDC. Those who died or underwent cardiac transplantation were grouped as “nonsurvivors” (n = 26). The remaining children who either completely recovered or experienced chronic dilated cardiomyopathy were grouped as “survivors” (n = 23). The median age overall was 1.25 years (range 0.1–17 years). The follow-up echocardiograms of the survivors showed significant improvement in left ventricle size, systolic function, left atrial volume, and MR grade, whereas these parameters did not change in the nonsurvivor group. The use of inotropic medications at initial presentation was an independent predictor of death or cardiac transplantation (p < 0.05). The presence of moderate to severe MR at diagnosis also was predictive of a worse outcome.
- 6 August 2013
- Published by Springer Nature in Pediatric Cardiology
- Vol. 35 (2) , 232-238
Severity of Mitral Regurgitation Predicts Risk of Death or Cardiac Transplantation in Children With Idiopathic Dilated Cardiomyopathy
Clinical outcomes among children with idiopathic dilated cardiomyopathy (IDC) are diverse, which makes the decision as to when a patient should be listed for a cardiac transplantation challenging. This study aimed to determine echocardiographic and clinical variables that can help clinicians identify those at highest risk for death or cardiac transplantation. The study was a single-center, retrospective chart review of children with IDC. Patients younger than 18 years with a diagnosis of IDC, as defined by a left ventricular end-diastolic dimension (LVEDD) z-score higher than 2, and fractional shortening of less than 28 % on the initial echocardiogram, were included in the study. Echocardiographic parameters including mitral regurgitation (MR) grade and certain clinical parameters at the time of presentation were assessed. A follow-up echocardiogram was similarly studied. The study included 49 children with IDC. Those who died or underwent cardiac transplantation were grouped as “nonsurvivors” (n = 26). The remaining children who either completely recovered or experienced chronic dilated cardiomyopathy were grouped as “survivors” (n = 23). The median age overall was 1.25 years (range 0.1–17 years). The follow-up echocardiograms of the survivors showed significant improvement in left ventricle size, systolic function, left atrial volume, and MR grade, whereas these parameters did not change in the nonsurvivor group. The use of inotropic medications at initial presentation was an independent predictor of death or cardiac transplantation (p < 0.05). The presence of moderate to severe MR at diagnosis also was predictive of a worse outcome.
- 5 April 2012
- Published by Springer Nature in Pediatric Cardiology
- Vol. 33 (8) , 1295-1300
The Ross Classification for Heart Failure in Children After 25 Years: A Review and an Age-Stratified Revision
Accurate grading of the presence and severity of heart failure (HF) signs and symptoms in infants and children remains challenging. It has been 25 years since the Ross classification was first used for this purpose. Since then, several modifications of the system have been used and others proposed. New evidence has shown that in addition to signs and symptoms, data from echocardiography, exercise testing, and biomarkers such as N-terminal pro-brain natriuretic peptide (NT-proBNP) all are useful in stratifying outcomes for children with HF. It also is apparent that grading of signs and symptoms in children is dependent on age because infants manifest HF differently than toddlers and older children. This review culminates in a proposed new age-based Ross classification for HF in children that incorporates the most useful data from the last two decades. Testing of this new system will be important to determine whether an age-stratified scoring system can unify the way communication of HF severity and research on HF in children is performed in the future.
- 5 April 2012
- Published by Springer Nature in Pediatric Cardiology
- Vol. 33 (8) , 1295-1300
The Ross Classification for Heart Failure in Children After 25 Years: A Review and an Age-Stratified Revision
Accurate grading of the presence and severity of heart failure (HF) signs and symptoms in infants and children remains challenging. It has been 25 years since the Ross classification was first used for this purpose. Since then, several modifications of the system have been used and others proposed. New evidence has shown that in addition to signs and symptoms, data from echocardiography, exercise testing, and biomarkers such as N-terminal pro-brain natriuretic peptide (NT-proBNP) all are useful in stratifying outcomes for children with HF. It also is apparent that grading of signs and symptoms in children is dependent on age because infants manifest HF differently than toddlers and older children. This review culminates in a proposed new age-based Ross classification for HF in children that incorporates the most useful data from the last two decades. Testing of this new system will be important to determine whether an age-stratified scoring system can unify the way communication of HF severity and research on HF in children is performed in the future.
- 31 March 2009
- Published by Elsevier in The Journal of Pediatrics
- Vol. 154 (3) , 311-312
Forming a Consortium to Promote Pediatric Cardiac Care in a Developing Country
- 31 March 2009
- Published by Elsevier in The Journal of Pediatrics
- Vol. 154 (3) , 311-312
Forming a Consortium to Promote Pediatric Cardiac Care in a Developing Country